Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of clofarabine in older patients with acute myeloid leukemia unsuitable for intensive chemotherapy
2004-004527-35Phase 2Completed
- Sponsor
- Bioenvision
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clofarabine in acute myeloid leukemia (AML), sponsored by Bioenvision. Primary endpoint: Overall response rate. Started Mar 2005; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2004-004527-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004527-35.